دورية أكاديمية

A lncRNA identifies Irf8 enhancer element in negative feedback control of dendritic cell differentiation.

التفاصيل البيبلوغرافية
العنوان: A lncRNA identifies Irf8 enhancer element in negative feedback control of dendritic cell differentiation.
المؤلفون: Xu H; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany., Li Z; Institute for Computational Genomics, RWTH Aachen University Medical School, Aachen, Germany., Kuo CC; Institute for Computational Genomics, RWTH Aachen University Medical School, Aachen, Germany., Götz K; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany., Look T; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany., de Toledo MAS; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany., Seré K; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany., Costa IG; Institute for Computational Genomics, RWTH Aachen University Medical School, Aachen, Germany., Zenke M; Department of Cell Biology, Institute of Biomedical Engineering, RWTH Aachen University Medical School, Aachen, Germany.; Helmholtz Institute for Biomedical Engineering, RWTH Aachen University, Aachen, Germany.; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany.
المصدر: ELife [Elife] 2023 Mar 14; Vol. 12. Date of Electronic Publication: 2023 Mar 14.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Cambridge, UK : eLife Sciences Publications, Ltd., 2012-
مواضيع طبية MeSH: RNA, Long Noncoding*/genetics , RNA, Long Noncoding*/metabolism, Mice ; Animals ; Feedback ; Interferon Regulatory Factors/metabolism ; Cell Differentiation/physiology ; Enhancer Elements, Genetic ; Dendritic Cells
مستخلص: Transcription factors play a determining role in lineage commitment and cell differentiation. Interferon regulatory factor 8 (IRF8) is a lineage determining transcription factor in hematopoiesis and master regulator of dendritic cells (DC), an important immune cell for immunity and tolerance. IRF8 is prominently upregulated in DC development by autoactivation and controls both DC differentiation and function. However, it is unclear how Irf8 autoactivation is controlled and eventually limited. Here, we identified a novel long non-coding RNA transcribed from the +32 kb enhancer downstream of Irf8 transcription start site and expressed specifically in mouse plasmacytoid DC (pDC), referred to as lncIrf8 . The lncIrf8 locus interacts with the lrf8 promoter and shows differential epigenetic signatures in pDC versus classical DC type 1 (cDC1). Interestingly, a sequence element of the lncIrf8 promoter, but not lncIrf8 itself, is crucial for mouse pDC and cDC1 differentiation, and this sequence element confers feedback inhibition of Irf8 expression. Taken together, in DC development Irf8 autoactivation is first initiated by flanking enhancers and then second controlled by feedback inhibition through the lncIrf8 promoter element in the +32 kb enhancer. Our work reveals a previously unrecognized negative feedback loop of Irf8 that orchestrates its own expression and thereby controls DC differentiation.
Competing Interests: HX, ZL, CK, KG, TL, Md, KS, IC, MZ No competing interests declared
(© 2023, Xu et al.)
References: Bioinformatics. 2014 Dec 15;30(24):3467-75. (PMID: 25371479)
Int J Hematol. 2015 Apr;101(4):342-51. (PMID: 25749660)
J Immunol. 2010 Nov 1;185(9):5326-35. (PMID: 20881193)
J Immunol. 2003 Feb 1;170(3):1131-5. (PMID: 12538667)
Nat Biotechnol. 1997 Feb;15(2):142-5. (PMID: 9035138)
Nat Methods. 2017 Oct;14(10):959-962. (PMID: 28846090)
Nucleic Acids Res. 2015 Nov 16;43(20):9680-93. (PMID: 26476451)
Nat Rev Immunol. 2006 Sep;6(9):644-58. (PMID: 16932750)
Nat Commun. 2020 Jun 1;11(1):2722. (PMID: 32483172)
Mol Immunol. 2020 Oct;126:25-30. (PMID: 32739721)
Virology. 1973 Apr;52(2):456-67. (PMID: 4705382)
Nat Rev Genet. 2021 Mar;22(3):154-168. (PMID: 33235358)
J Exp Med. 2002 Dec 2;196(11):1415-25. (PMID: 12461077)
Nucleic Acids Res. 2016 Nov 16;44(20):e153. (PMID: 27484474)
Elife. 2023 Mar 14;12:. (PMID: 36916882)
Genome Biol. 2019 Feb 26;20(1):45. (PMID: 30808370)
Nat Immunol. 2019 Sep;20(9):1174-1185. (PMID: 31406377)
J Immunol. 2012 Oct 1;189(7):3548-56. (PMID: 22942423)
Nature. 2015 Jan 29;517(7536):583-8. (PMID: 25494202)
Cell Metab. 2015 May 5;21(5):764-776. (PMID: 25921091)
Mol Cell Biol. 2005 Apr;25(7):2832-45. (PMID: 15767686)
J Clin Invest. 2008 Mar;118(3):853-67. (PMID: 18246201)
Nat Methods. 2013 Aug;10(8):795-803. (PMID: 23749299)
Nature. 1986 Oct 9-15;323(6088):544-8. (PMID: 3020434)
Bioinformatics. 2009 Dec 1;25(23):3181-2. (PMID: 19773334)
J Biol Chem. 2014 Dec 5;289(49):34250-7. (PMID: 25331958)
Eur J Immunol. 2022 Oct 27;:. (PMID: 36303448)
Nat Commun. 2017 Dec 12;8(1):2085. (PMID: 29233972)
Nat Rev Immunol. 2022 Feb;22(2):67-68. (PMID: 35027741)
Nature. 2009 Dec 3;462(7273):587-94. (PMID: 19956253)
Nat Commun. 2014 Sep 19;5:4978. (PMID: 25236377)
Nat Protoc. 2012 Mar 01;7(3):562-78. (PMID: 22383036)
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92. (PMID: 31701148)
Bioinformatics. 2011 Jul 1;27(13):i275-82. (PMID: 21685081)
Cell Rep. 2013 May 30;3(5):1617-28. (PMID: 23623495)
BMC Mol Biol. 2018 Mar 27;19(1):5. (PMID: 29587652)
Genome Biol. 2018 Feb 6;19(1):15. (PMID: 29409532)
Mol Cell. 2014 Dec 18;56(6):749-62. (PMID: 25453760)
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6456-65. (PMID: 26499245)
EMBO J. 1986 Feb;5(2):387-97. (PMID: 3011406)
Annu Rev Immunol. 2021 Apr 26;39:131-166. (PMID: 33481643)
Nature. 2018 Jan 24;553(7689):418-426. (PMID: 29364285)
Mol Cell Biol. 2000 Jan;20(2):713-23. (PMID: 10611250)
Nat Protoc. 2006;1(6):2742-5. (PMID: 17406530)
J Exp Med. 2022 Feb 7;219(2):. (PMID: 34958351)
Nat Immunol. 2019 Sep;20(9):1161-1173. (PMID: 31406378)
Nat Commun. 2021 Jan 22;12(1):531. (PMID: 33483495)
Nat Biotechnol. 2014 Sep;32(9):941-6. (PMID: 24952903)
Immunity. 2016 Sep 20;45(3):626-640. (PMID: 27637148)
Science. 1995 Sep 8;269(5229):1427-9. (PMID: 7660125)
Nature. 2017 Jul 27;547(7664):413-418. (PMID: 28723893)
BMC Bioinformatics. 2009 Mar 10;10:82. (PMID: 19284541)
Nat Genet. 2021 Apr;53(4):426-427. (PMID: 33795865)
Nat Biotechnol. 2018 Dec 03;:. (PMID: 30531897)
J Virol. 2014 Dec;88(24):14412-25. (PMID: 25297993)
Mol Immunol. 2020 Dec;128:116-124. (PMID: 33126080)
Nat Immunol. 2021 Mar;22(3):301-311. (PMID: 33603226)
Nat Immunol. 2018 Jul;19(7):711-722. (PMID: 29925996)
Proc Natl Acad Sci U S A. 2022 Aug 23;119(34):e2207009119. (PMID: 35969760)
Immunity. 2020 Oct 13;53(4):759-774.e9. (PMID: 32795402)
Nat Immunol. 2019 Jul;20(7):852-864. (PMID: 31213723)
Nat Rev Immunol. 2021 Feb;21(2):101-115. (PMID: 32908299)
Nat Methods. 2012 Mar 04;9(4):357-9. (PMID: 22388286)
Exp Hematol. 2020 Aug;88:1-6. (PMID: 32653531)
Immunity. 2020 Jun 16;52(6):942-956. (PMID: 32553180)
Nat Immunol. 2015 Jul;16(7):708-17. (PMID: 26054719)
Front Immunol. 2022 Feb 25;13:794776. (PMID: 35281062)
Cell. 2016 Nov 17;167(5):1170-1187. (PMID: 27863239)
Nature. 2019 May;569(7756):345-354. (PMID: 31092938)
Bioinformatics. 2013 Jan 1;29(1):15-21. (PMID: 23104886)
Biotechnol Prog. 2007 Mar-Apr;23(2):480-7. (PMID: 17373825)
Mol Cell. 2012 Sep 14;47(5):810-22. (PMID: 22940246)
Nat Struct Mol Biol. 2020 Jun;27(6):521-528. (PMID: 32514177)
Cell Death Dis. 2016 Jun 09;7(6):e2260. (PMID: 27277682)
Annu Rev Immunol. 2008;26:535-84. (PMID: 18303999)
Nat Commun. 2022 Feb 9;13(1):773. (PMID: 35140205)
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773. (PMID: 30357393)
Cell. 2014 Oct 9;159(2):440-55. (PMID: 25263330)
Blood. 2019 Apr 25;133(17):1803-1813. (PMID: 30796024)
Nat Protoc. 2022 Feb;17(2):445-475. (PMID: 35121852)
Nucleic Acids Res. 2013 Apr 1;41(6):e74. (PMID: 23335781)
Immunity. 2020 Aug 18;53(2):353-370.e8. (PMID: 32735845)
Eur J Immunol. 2022 Nov;52(11):1859-1862. (PMID: 34826338)
Nat Rev Mol Cell Biol. 2021 Feb;22(2):96-118. (PMID: 33353982)
Nat Methods. 2009 May;6(5):343-5. (PMID: 19363495)
Nat Rev Immunol. 2012 Jan 25;12(2):101-13. (PMID: 22273772)
Nat Commun. 2022 Jun 23;13(1):3595. (PMID: 35739121)
J Exp Med. 2018 Sep 3;215(9):2265-2278. (PMID: 30087163)
Mol Cell Biol. 1986 Jun;6(6):2098-105. (PMID: 3023918)
فهرسة مساهمة: Keywords: CRISPR; dendritic cell; enhancer; feedback loop; immunology; inflammation; interferon regulatory factor 8; lncRNA; mouse
سلسلة جزيئية: GEO GSE198651; GSE118221; GSE36099; GSE73143; GSE57563; GSE64767; GSE114313; GSE188992
المشرفين على المادة: 0 (interferon regulatory factor-8)
0 (RNA, Long Noncoding)
0 (Interferon Regulatory Factors)
تواريخ الأحداث: Date Created: 20230314 Date Completed: 20230329 Latest Revision: 20230405
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10042546
DOI: 10.7554/eLife.83342
PMID: 36916882
قاعدة البيانات: MEDLINE
الوصف
تدمد:2050-084X
DOI:10.7554/eLife.83342